NetworkNewsBreaks – InMed Pharmaceuticals Inc. (
Post# of 228
InMed Pharmaceuticals (NASDAQ: INM), a leader in the development, manufacturing and commercialization of rare cannabinoids, will be participating in the 4th annual Cowen Cannabis Conference. InMed’s management team will be presenting in the three-day event, which is scheduled for Nov. 29–Dec. 1, 2021. During the virtual conference, InMed representatives will meet virtually one-on-one with institutional and corporate clients of the firm. The agenda for the annual cannabis conference features topical panel discussions with C-Suite presenters. The event is hosted by Cowen Research and Washington Research Group analysts.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer